A new report from the American Lung Association reveals both progress and persistent challenges in the fight against lung ...

A special last wish was granted for a Calaveras County hospice patient facing a daunting diagnosis. Janet McAnnally, 79, was ...

The lung cancer survival rate has improved 26% in the last five years, according to the American Lung Association’s ...

Lung cancer is the leading cause of cancer deaths in New Hampshire and across the U.S., but the American Lung Association’s 2024 State of Lung Cancer report indicates ...

The good news is, with advanced medical technologies, physicians now are better able to discover and treat diseases in their ...

Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers ...

The test also demonstrated a negative predictive value (NPV) of 99.8 percent for determining if lung cancer would be discovered on a screening Chest CT. Early detection is key to improving patient ...

“It’s the first clinically validated test on the market,” Zaidi told Pittsburgh Magazine. “And one of the most highly ...

Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...

As previously reported, Wolfe Research initiated coverage of Veracyte (VCYT) with an Outperform rating and $50 price target The genomic ...

bioAffinity Technologies, Inc. is a biotechnology company dedicated to providing noninvasive diagnostic tests for early-stage lung cancer and other lung diseases ... substantial progress in expanding ...

The global neuroendocrine carcinoma treatment market is poised for substantial growth, with revenue expected to reach USD ...